Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2026-05-30 @ 10:31 PM
Study NCT ID:
NCT01155193
Status:
COMPLETED
Last Update Posted:
2018-10-29
First Post:
2010-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Respiratory Syncytial Virus Infections | View |